Dark

Check out our API

ONCS
OncoSec Medical Incorporated
stock NASDAQ

Inactive

Jun 23, 2023

0.2772USD+31.874%(+0.0670)52,491,052

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-0.21)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Dec 17, 2021

09:10AM EST OncoSec Announces Changes to its Board of Directors PR Newswire

Dec 7, 2021

08:26AM EST The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar Benzinga

Dec 6, 2021

06:07AM EST The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More Benzinga

Nov 12, 2021

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

Nov 8, 2021

08:29AM EST The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Benzinga

Nov 2, 2021

08:03AM EDT OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from PR Newswire

Oct 21, 2021

12:11PM EDT The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO Benzinga

12:10PM EDT OncoSec CSO Chris Twitty To Step Down Benzinga

Oct 20, 2021

04:02PM EDT OncoSec Provides Business Update PR Newswire

Oct 14, 2021

04:16PM EDT Hearing BTIG Assumes Coverage On OncoSec Medical With Buy Rating And $10 Price Target Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

04:01PM EDT OncoSec Provides Leadership Update PR Newswire

Jul 26, 2021

08:31AM EDT OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference PR Newswire

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 7, 2021

02:52PM EDT Mid-Afternoon Market Update: Dow Rises 70 Points; IDEAYA Biosciences Shares Slide Benzinga

12:18PM EDT Mid-Day Market Update: Crude Oil Down 2.5%; Opiant Pharmaceuticals Shares Jump Benzinga

10:56AM EDT Mid-Morning Market Update: Markets Mostly Flat; MSC Industrial Direct Tops Q3 Views Benzinga

07:58AM EDT OncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma Benzinga

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jul 6, 2021

04:02PM EDT OncoSec Enters Into Collaboration Agreement With Merck For A Pivotal Global Phase 3 Study, KEYNOTE-C87, Of TAVO Combined With KEYTRUDA For Late-Stage Metastatic Melanoma Benzinga

04:01PM EDT Phase 3 Study, KEYNOTE-C87, of TAVO(tm) Combined with KEYTRUDA(r) for Late-Stage Metastatic Melanoma PR Newswire

Jun 24, 2021

04:31PM EDT OncoSec Appoints Brian Leuthner as Interim Chief Executive Officer PR Newswire

Jun 14, 2021

08:32AM EDT OncoSec Appoints Jeffrey Silverman As VP Of Product Engineering RTTNews

08:31AM EDT OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey PR Newswire

May 27, 2021

08:31AM EDT OncoSec to Present at the Raymond James Human Health Innovation Conference PR Newswire

May 18, 2021

10:03AM EDT OncoSec Medical Granted U.S. Patent Titled 'Method and device for treating microscopic residual tumors remaining in tissues following surgical resection' Benzinga

May 17, 2021

08:36AM EDT OncoSec Appoints Robert Schinagl As VP Of Program And Alliance Management RTTNews

08:31AM EDT OncoSec Appoints Robert M. Schinagl, Ph.D. as Vice President of Program and PR Newswire

May 3, 2021

10:24AM EDT OncoSec Aims to Treat Cancer with what the Body Makes Naturally Benzinga

Apr 15, 2021

08:39AM EDT OncoSec To Present Encore Interim Data From The KEYNOTE-695 Phase 2b Clinical Trial At 10th World Congress Of Melanoma Benzinga

08:31AM EDT OncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical PR Newswire

Apr 14, 2021

08:33AM EDT OncoSec Says Receives CE Mark Certification For Commercial Electroportation Device 'GenPulse' For Treatment Of Solid Tumors Benzinga

08:31AM EDT OncoSec Receives CE Mark Certification for its Commercial Electroporation PR Newswire

Mar 25, 2021

02:45PM EDT Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference Benzinga

08:40AM EDT OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 PR Newswire

Mar 23, 2021

07:12PM EDT Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021 Benzinga

Mar 8, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021 Benzinga

08:29AM EST BTIG Initiates Coverage On OncoSec Medical with Buy Rating, Announces Price Target of $10 Benzinga

Mar 1, 2021

09:07AM EST OncoSec Highlights Publication Of Research In 'Clinical Cancer Research Journal' Demonstrating Ability Of Co.'s TAVO To 'activate tumor antigen specific antitumor immunity in patients with triple negative breast cancer' Benzinga

09:05AM EST ONCS : TAVO Therapy Safe And Effective At Increasing Tumor Antigen Specific Presentation & Recruitment Of CD8+ T Cells RTTNews

09:01AM EST the Therapeutic Potential of Lead Product Candidate, TAVO(tm), in Triple Negative Breast Cancer PR Newswire

Feb 23, 2021

09:07AM EST OncoSec Announces Approval Of $2.5M In Tax Credits From NJEDA NOL Program Benzinga

09:03AM EST OncoSec Announces Approval of $2.5 Million in NJEDA NOL Program Tax Benefits PR Newswire

Feb 18, 2021

08:33AM EST OncoSec Appoints Bridget O'Keeffe As VP Of Clinical Development RTTNews

08:31AM EST OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical PR Newswire

Feb 2, 2021

09:01AM EST OncoSec Strengthens Management Team With Two New Appointments PR Newswire

08:05AM EST The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment Benzinga

Jan 27, 2021

09:19AM EST OncoSec Announces First Subjects Dosed In Phase 1 Trial Of CORVax12, COVID-19 Vaccine Candidate RTTNews

09:01AM EST OncoSec Announces First Subjects Dosed In Phase 1 Trial Of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) With An Enhanced SARS-CoV-2 Spike Protein Benzinga

09:01AM EST COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein PR Newswire

Jan 25, 2021

04:12PM EST OncoSec Medical Closes $42.0 Mln Public Offering Of Common Stock RTTNews

04:00PM EST OncoSec Medical Closes $42.0 Million Public Offering of Common Stock PR Newswire

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

10:48AM EST OncoSec Medical shares were trading lower after the company reported an offering of common stock. Benzinga

08:38AM EST OncoSec Medical Prices Public Offering Of 7.71 Mln Shares At $5.45 Per Share RTTNews

08:34AM EST OncoSec Medical Announces Pricing Of $42M Offering At $5.45/Share Benzinga

08:31AM EST OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common PR Newswire

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

04:36PM EST OncoSec Medical Announces Proposed Public Offering of Common Stock PR Newswire

04:35PM EST OncoSec Medical Reports Offering Of Common Stock, No Size Disclosed Benzinga

Jan 19, 2021

09:00AM EST Sirtex Medical announces collaboration update with OncoSec Medical PR Newswire

08:41AM EST OncoSec Reaches Option Deal With Sirtex Medical To Co-Promote TAVO RTTNews

08:35AM EST OncoSec Enters Into Option Agreement With Sirtex Medical To Co-Promote TAVO; Sirtex To Pay OncoSec $5M For Non-Exclusive Option Benzinga

08:31AM EST OncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO(tm) PR Newswire

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Jan 8, 2021

09:03AM EST OncoSec Says First Patient Dosed In Phase 2 Trial Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma RTTNews

09:01AM EST OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO(tm) Plus PR Newswire

09:00AM EST OneSec Announces First Patient Dosed In Phase 2 Trial Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma Benzinga

Jan 6, 2021

10:22AM EST Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 18, 2020

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

Dec 10, 2020

09:05AM EST OncoSec Medical Reports European Patent Office Issued Notices Of Intent To Grant For 2 Patent Applications Benzinga

09:02AM EST OncoSec Strengthens IP Portfolio with Allowance of Two European Patent PR Newswire

Dec 5, 2020

09:01AM EST Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids Benzinga

Dec 3, 2020

09:08AM EST OncoSec Reports Publication In International Journal Of Surgery Case Reports RTTNews

09:03AM EST OncoSec Announces Publication in International Journal of Surgery Case Reports PR Newswire

Nov 24, 2020

09:36AM EST OncoSec Medical Inc. (ONCS) said Tuesday that it has licensed the exclusive rights to the Cliniporator electroporation or gene electrotransfer platform from IGEA Clinical Biophysics. RTTNews

09:06AM EST OncoSec Announces License Agreement For Cliniporator Gene Electrotransfer Platform Developed By IGEA RTTNews

09:02AM EST OncoSec Announces Exclusive License Agreement for Cliniporator(r) Gene PR Newswire

09:02AM EST OncoSec Reports Exclusive License Deal For Cliniporator Gene Electrotransfer Platform, No Terms Disclosed Benzinga

Nov 18, 2020

02:07PM EST Alpha Holdings In Amended 13D Filing Reports 6.76% Stake In Oncosec Medical As Of Nov. 16 Benzinga

09:09AM EST OncoSec Announces KEYNOTE-695 Reaches Full Enrollment RTTNews

09:05AM EST OncoSec Provides Highlights From Analyst & Investor Day And SITC 2020, Announces KEYNOTE-695 Reaches Full Enrollment Benzinga

09:02AM EST OncoSec Provides Highlights from Analyst & Investor Day and SITC 2020 and PR Newswire

Nov 13, 2020

07:40AM EST The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations Benzinga

Nov 12, 2020

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

Nov 11, 2020

07:38AM EST The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap Benzinga

Nov 9, 2020

09:38AM EST OncoSec Earlier Reported Interim Data From KEYNOTE-695 Trial In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma At Society For Immunotherapy Of Cancer Meeting Nov. 11, 13 Benzinga

08:43AM EST OncoSec Announces Positive Interim Data From KEYNOTE-695 Trial In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma RTTNews

08:37AM EST OncoSec Announces Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 PR Newswire

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 5, 2020

09:11AM EST OncoSec Hosting Investor, Analyst Day Webinar Showcasing Positive KEYNOTE-695 Data In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma Benzinga

09:03AM EST OncoSec Medical Reports Positive KEYNOTE-695 Data In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma RTTNews

09:02AM EST OncoSec Hosting an Investor and Analyst Day Webinar Showcasing Positive PR Newswire

Nov 3, 2020

09:02AM EST OncoSec To Present Positive Interim Data From KEYNOTE-695 Trial In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma At SITC 2020 Nov. 9-14 Benzinga

09:02AM EST OncoSec To Present Positive Interim Data From KEYNOTE-695 Trial In Anti-PD-1 Checkpoint Refractory Metastatic Melanoma RTTNews

09:01AM EST OncoSec to Present Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 PR Newswire

Oct 29, 2020

09:31AM EDT OncoSec Medical Reports FDA Clearance Of Its Investigational New Drug Application For Initiation Of Phase 1 Trial Of Its CORVax12 Vaccine Candidate For COVID-19 Benzinga

09:28AM EDT OncoSec Announces FDA Clearance Of IND Application For Initiation Of Phase 1 Clinical Trial Of Its CORVax12 Vaccine Candidate For COVID-19 Benzinga

09:22AM EDT OncoSec Medical Says FDA Approved IND Application For First-in-human Phase 1 Trial For CORVax12 RTTNews

09:10AM EDT OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 PR Newswire

Oct 12, 2020

08:34AM EDT OncoSec Announces Appointment Of Senior VP, Chief Clinical Development Officer Benzinga

08:31AM EDT OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, PR Newswire

Oct 6, 2020

03:08PM EDT OncoSec Medical shares are trading higher after the company announced it received a new US patent expanding its coverage of the TAVO and its gene delivery program. Benzinga

08:38AM EDT OncoSec Announces Issuance Of New US Patent Expanding Coverage Of TAVO And Its Gene Delivery Platform Benzinga

08:31AM EDT OncoSec Announces Issuance of New U.S. Patent Expanding Coverage of TAVO(tm) PR Newswire

Aug 27, 2020

08:36AM EDT OncoSec Announces Initiation Of Phase 2 Study At The Moffitt Cancer Center To Evaluate Combination Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma Benzinga

08:35AM EDT OncoSec Begins Phase 2 Study To Evaluate The Combination Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma RTTNews

08:31AM EDT Evaluate the Combination of TAVO plus OPDIVO(r) as Neoadjuvant Therapy for Melanoma PR Newswire

Aug 25, 2020

08:31AM EDT OncoSec to Present at the LD 500 Virtual Conference on September 2, 2020 PR Newswire

Aug 17, 2020

12:49PM EDT OncoSec Medical shares are trading lower after the company announced a common stock offering of 4.61 million shares at $3.25 per share. Benzinga

07:19AM EDT OncoSec Medical Prices 4.61M Share Offering at $3.25/Share Benzinga

12:07AM EDT OncoSec Medical Enters Purchase Agreements For Purchase Of 4.61 Mln Shares At $3.25/Shr RTTNews

Aug 16, 2020

11:56PM EDT OncoSec Medical Incorporated Announces Pricing of Public Offering PR Newswire

Aug 14, 2020

08:42PM EDT OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock PR Newswire

Aug 10, 2020

08:31AM EDT OncoSec to Present at the BTIG Virtual Biotechnology Conference 2020 on PR Newswire

Jul 27, 2020

12:03PM EDT Dawson James Initiates Coverage On OncoSec Medical with Buy Rating, Announces Price Target of $10 Benzinga

09:12AM EDT OncoSec Names Kellie Malloy Foerter COO RTTNews

09:04AM EDT OncoSec Appoints Kellie Malloy Foerter As Chief Operating Officer Benzinga

Jul 20, 2020

05:11AM EDT 80 Biggest Movers From Friday Benzinga

Jul 15, 2020

04:49AM EDT 55 Biggest Movers From Yesterday Benzinga

Jul 13, 2020

09:08AM EDT OncoSec Announces Promising Potential Of Novel DNA-encodable Vaccine Candidate, CORVax12 To Prevent COVID-19 RTTNews

09:02AM EDT OncoSec's Highlights Episode Of NBC TV Portland's 'Straight Talk' Discussing Coronavirus Vaccine Candidate Benzinga

09:01AM EDT OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program PR Newswire

Share